We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
- Authors
Andreasen, N; Hesse, C; Davidsson, P; Minthon, L; Wallin, A; Winblad, B; Vanderstichele, H; Vanmechelen, E; Blennow, K
- Abstract
To study the diagnostic potential of the 42 amino acid form of beta-amyloid (beta-amyloid(1-42)) in cerebrospinal fluid (CSF) as a biochemical marker for Alzheimer disease (AD), the intra-individual biological variation of CSF-beta-amyloid(1-42) level in patients with AD, and the possible effects of differential binding between beta-amyloid and apolipoprotein E isoforms on CSF-beta-amyloid(1-42) levels.
- Publication
Archives of neurology, 1999, Vol 56, Issue 6, p673
- ISSN
0003-9942
- Publication type
Journal Article
- DOI
10.1001/archneur.56.6.673